These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2941083)

  • 1. Inhibition of prostaglandin E2 restores defective lymphocyte proliferation and cell-mediated lympholysis in recipients after allogeneic marrow grafting.
    Klingemann HG; Tsoi MS; Storb R
    Blood; 1986 Jul; 68(1):102-7. PubMed ID: 2941083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibronectin restores defective in vitro proliferation of patients' lymphocytes after marrow grafting.
    Klingemann HG; Tsoi MS; Storb R
    Transplantation; 1986 Oct; 42(4):412-7. PubMed ID: 2945302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular interactions in marrow-grafted patients. III. Normal interleukin 1 and defective interleukin 2 production in short-term patients and in those with chronic graft-versus-host disease.
    Brkic S; Tsoi MS; Mori T; Lachman L; Gillis S; Thomas ED; Storb R
    Transplantation; 1985 Jan; 39(1):30-5. PubMed ID: 3880962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in proliferation and cytotoxic cell development in human mixed lymphocyte cultures in the presence of very low concentrations of LPS: role of IL-1 and prostaglandin E2.
    Spear GT; Marshall P; Teodorescu M
    Clin Immunol Immunopathol; 1986 Jan; 38(1):32-46. PubMed ID: 3000663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonspecific suppressor cells in patients with chronic graft-vs-host disease after marrow grafting.
    Tsoi MS; Storb R; Dobbs S; Kopecky KJ; Santos E; Weiden PL; Thomas ED
    J Immunol; 1979 Nov; 123(5):1970-6. PubMed ID: 39962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific tolerance and immunocompetence in haploidentical, but not in completely allogeneic, canine chimeras treated with methotrexate and cyclosporine.
    Deeg HJ; Severns E; Raff RF; Sale GE; Storb R
    Transplantation; 1987 Nov; 44(5):621-32. PubMed ID: 2961110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of mixed lymphocyte culture with chronic graft-versus-host disease following allogeneic stem cell transplantation.
    Visentainer JE; Lieber SR; Persoli LB; de Souza Lima SC; Vigorito AC; Aranha FJ; Eid KA; Oliveira GB; Miranda EC; de Souza CA
    Braz J Med Biol Res; 2002 May; 35(5):567-72. PubMed ID: 12011942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E2 inhibits human T-cell proliferation after crosslinking of the CD3-Ti complex by directly affecting T cells at an early step of the activation process.
    Vercammen C; Ceuppens JL
    Cell Immunol; 1987 Jan; 104(1):24-36. PubMed ID: 2948675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular interactions in marrow-grafted patients. II. Normal monocyte antigen-presenting and defective T-cell-proliferative functions early after grafting and during chronic graft-versus-host disease.
    Tsoi MS; Dobbs S; Brkic S; Ramberg R; Thomas ED; Storb R
    Transplantation; 1984 Jun; 37(6):556-61. PubMed ID: 6233768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of calcineurin abrogates while inhibition of mTOR promotes regulatory T cell expansion and graft-versus-host disease protection by IL-2 in allogeneic bone marrow transplantation.
    Satake A; Schmidt AM; Nomura S; Kambayashi T
    PLoS One; 2014; 9(3):e92888. PubMed ID: 24658577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoregulation by macrophages. III. Prostaglandin E suppresses lymphocyte activation but not macrophage effector function during Salmonella enteritidis infection.
    Cahill J; Hopper KE
    Int J Immunopharmacol; 1984; 6(1):9-17. PubMed ID: 6327542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of lymphocyte alloreactivity by early gestational human decidua. II. Characterization of the suppressor mechanisms.
    Lala PK; Kennedy TG; Parhar RS
    Cell Immunol; 1988 Oct; 116(2):411-22. PubMed ID: 3263215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice].
    Cao J; Li L; Chen C; Zeng LY; Li ZY; Pan XY; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):83-8. PubMed ID: 21429372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular interactions in marrow-grafted patients. I. Impairment of cell-mediated lympholysis associated with graft-vs-host disease and the effect of interleukin 2.
    Mori T; Tsoi MS; Gillis S; Santos E; Thomas ED; Storb R
    J Immunol; 1983 Feb; 130(2):712-6. PubMed ID: 6217250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular immunity in Q fever: modulation of responsiveness by a suppressor T cell-monocyte circuit.
    Koster FT; Williams JC; Goodwin JS
    J Immunol; 1985 Aug; 135(2):1067-72. PubMed ID: 2409135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the mixed lymphocyte culture (MLC) assay as a method for selecting unrelated donors for marrow transplantation.
    Mickelson EM; Longton G; Anasetti C; Petersdorf E; Martin P; Guthrie LA; Hansen JA
    Tissue Antigens; 1996 Jan; 47(1):27-36. PubMed ID: 8929710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased incidence of murine graft-versus-host disease after allogeneic bone marrow transplantation by previous infusion of syngeneic bone marrow cells.
    Waer M; Ang KK; van der Schueren E; Vandeputte M
    Transplantation; 1984 Oct; 38(4):396-400. PubMed ID: 6238457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation-related complications predicted by cytokine gene expression in the mixed lymphocyte culture in allogeneic bone marrow transplants.
    Tanaka J; Imamura M; Kasai M; Sakurada K
    Leuk Lymphoma; 1995 Sep; 19(1-2):27-32. PubMed ID: 8574169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ineffective cellular interaction and interleukin 2 deficiency causing T cell defects in human allogeneic marrow recipients early after grafting and in those with chronic graft-versus-host disease.
    Tsoi MS; Mori T; Brkic S; Dobbs S; Gillis S; Santos E; Thomas ED; Storb R
    Transplant Proc; 1984 Dec; 16(6):1470-2. PubMed ID: 6390848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanisms of inhibition of human IL 2 production. II. PGE2 induction of suppressor T lymphocytes.
    Chouaib S; Chatenoud L; Klatzmann D; Fradelizi D
    J Immunol; 1984 Apr; 132(4):1851-7. PubMed ID: 6230395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.